NK Tolerance and Hematopoietic Cell Transplantation
NK Tolerance and Hematopoietic Cell Transplantation
批准号:
8197289
负责人:
KATHARINE C HSU
金额:
$41.65万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-05 至 2014-11-30
关键词:
Activities of Daily LivingAdoptedAllogenicAutoimmune ProcessAutoimmunityAutologousBehaviorBlood CirculationCell LineCell TransplantsCellsClinicalColorCompetenceComplementary DNADendritic CellsDevelopmentEnvironmentExhibitsFlow CytometryGenesHLA AntigensHematopoiesisHematopoieticHistocompatibility Antigens Class IHumanImmuneImmune systemIndividualInterferonsLangerhans cellLeadLicensingLigandsMHC Class I GenesMalignant NeoplasmsModelingNatural Killer CellsPatientsProductionSelf ToleranceSiblingsStromal CellsT-LymphocyteTestingTissuesTransplantationVariantVirus Diseasesabstractinganergycancer cellcell injurycytotoxichematopoietic cell transplantationin vivokillingsleukemiareceptorreconstitutionresponsesingle cell analysissmall hairpin RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Natural killer (NK) cells are an important component of the innate immune system and are capable
of killing virally infected cells and malignant cells. Autoimmune NK activity is avoided by inhibitory
receptors such as the killer Ig-like receptors (KIR) that recognize self-human leukocyte antigens
(HLA) class I molecules present on all autologous tissue cells. NK cells, however, frequently
express KIRs for which the individual lacks the appropriate HLA class I ligand, and yet these NK
cells do not exhibit autoreactive behavior. This has led to the "licensing model" where only NK cells
expressing KIR for self-HLA ligands are functionally competent and capable of effector activity.
How NK cells expressing KIR for self-HLA achieve functional competence while NK cells
expressing KIR for non-self HLA achieve tolerance to self is the focus of our proposed
studies. Using 6-color flow cytometry for single cell analysis of NK response to study individuals
whose functional KIR repertoire is comprised nearly completely by inhibitory receptors, we
demonstrate that in the steady state individual, expression of inhibitory KIR for self-HLA class I
confers functional competence to the NK cell as assessed by intracellular IFN-¿ production to class
I negative targets. Furthermore, there is a correlation between increased effector function and: 1)
higher qualitative numbers of KIR specific for self-HLA, and 2) higher NK expression of HLA. We
hypothesize that functional competence in part results from HLA and KIR molecules inherent to the
cell, whose interaction is necessary for effector function. In Specific Aim 1, using lentiviral
constructs to introduce class I shRNA or KIR/HLA cDNA, we will study how altered expression of
KIR or HLA in primary NK cells and NK cell lines perturbs the functional capacity of NK cells.
Following allogeneic hematopoietic cell transplantation (HCT), we have found that NK cells
expressing KIR for non-self HLA are initially endowed with functional capacity, but become
hyporesponsive and tolerant to self by day 100. This observation supports the model that the na¿ve
NK cell achieves self-tolerance after a period in the circulation of interaction with autologous cells,
transitioning from a state where all inhibitory KIR receptors are capable of recognizing lack of ligand
("missing ligand") to a mature state where the appropriate inhibitory KIR recognize lack of self-
ligand ("missing self"). Allogeneic HCT offers a unique in vivo environment in which hematopoiesis
in the early post-transplant period provides a window to examine NK cell development. We
hypothesize that functional competence may be sustained through trans-interaction with HLA-
expressing autologous cells, and potentially autoreactive cells expressing KIR for non-self HLA are
rendered anergic through lack of class I engagement. Specific Aim 2 seeks to demonstrate that
cells that would otherwise adopt a hyporesponsive fate can retain functional competence if cultured
during development in an environment expressing non-self class I ligands as presented by
allogeneic Langerhans cells or stromal cell transfectants. Elucidating how NK cells achieve
functional competence not only has implications for NK alloreactivity in the transplant setting, but
also for judicious application of NK cells as adoptive cellular therapy for malignancies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1158/1078-0432.ccr-09-1720
发表时间:
2009-12-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
[Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung NK, Hsu KC]
通讯作者:
Hsu KC
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
-
批准号:10390447
-
项目类别:
-
资助金额:$70.98万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
-
批准号:10322105
-
项目类别:
-
资助金额:$60.84万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
-
批准号:10590647
-
项目类别:
-
资助金额:$73.31万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
Machine learning with immunogenetics for the prediction of hematopoietic cell transplant outcomes
-
批准号:10534187
-
项目类别:
-
资助金额:$59.59万
-
财政年份:2021
-
负责人:KATHARINE C HSU
-
依托单位:
Natural killer cell and T-cell crosstalk in CMV infection
-
批准号:9398188
-
项目类别:
-
资助金额:$30.63万
-
财政年份:2017
-
负责人:KATHARINE C HSU
-
依托单位:
KIR and HLA in cis and trans cooperatively shape human NK education
-
批准号:9160652
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
KIR and HLA in cis and trans cooperatively shape human NK education
-
批准号:9310137
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
Phase I study humanized 3F8 MoAb (IND 112594) and NK cells (IND BB-13399) for neuroblastoma
-
批准号:9488351
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2016
-
负责人:KATHARINE C HSU
-
依托单位:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
-
批准号:9271228
-
项目类别:
-
资助金额:$57.34万
-
财政年份:2015
-
负责人:KATHARINE C HSU
-
依托单位:
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
-
批准号:8865414
-
项目类别:
-
资助金额:$42.1万
-
财政年份:2015
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8508896
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8217684
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8544192
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Phase 1 Study of Immunotherapy with NK Cells anti-GD2 for Neuroblastoma
-
批准号:8730476
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8731836
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
Combination immunotherapy for neuroblastoma: model of innate tumor immunity
-
批准号:8373670
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2012
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7743072
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7383207
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Tolerance and Hematopoietic Cell Transplantation
-
批准号:7536389
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2007
-
负责人:KATHARINE C HSU
-
依托单位:
NK Receptors and Bone Marrow Transplant Outcome
-
批准号:6704624
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2004
-
负责人:KATHARINE C HSU
-
依托单位:
海外基金